Capital World Investors »

Aeglea Biotherapeutics shares owned by Capital World Investors

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Capital World Investors from 13F filings

Historical chart of Capital World Investors investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Capital World Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Capital World Investors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.4M 200k 16.76
2025-06-30 $5.3M 351k 14.97
2025-03-31 $5.7M 351k 16.14
2024-12-31 $8.8M 379k 23.28